Cargando…

Is Hyperglycemia a Cardiovascular Risk Factor?

Detalles Bibliográficos
Autores principales:	Pistrosch, Frank, Natali, Andrea, Hanefeld, Markolf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2011
Materias:	Diabetes and Cardiovascular Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632149/ https://www.ncbi.nlm.nih.gov/pubmed/21525443 http://dx.doi.org/10.2337/dc11-s207

Ejemplares similares

Shifting the Disease Management Paradigm From Glucose: What are the cons?
por: Hanefeld, Markolf, et al.
Publicado: (2009)

Is Hyperglycemia a Causal Factor in Cardiovascular Disease?: Does proving this relationship really matter? Yes
por: Davidson, Jaime A., et al.
Publicado: (2009)

Postprandial Hyperglycemia and Glycemic Variability: Should we care?
por: Standl, Eberhard, et al.
Publicado: (2011)

Hypoglycemia and Cardiovascular Risks
por: Frier, Brian M., et al.
Publicado: (2011)

The metabolic vascular syndrome - guide to an individualized treatment
por: Hanefeld, Markolf, et al.
Publicado: (2016)

Natriuretic Peptide and High-Sensitivity Troponin for Cardiovascular Risk Prediction in Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study
por: Gori, Mauro, et al.
Publicado: (2016)

Glucose Control and Cardiovascular Disease: Is it important? No
por: Conget, Ignacio, et al.
Publicado: (2009)

Endothelial Dysfunction as a Target for Prevention of Cardiovascular Disease
por: Versari, Daniele, et al.
Publicado: (2009)

Is There Evidence That Oral Hypoglycemic Agents Reduce Cardiovascular Morbidity or Mortality? No
por: Kassem, Sameer A., et al.
Publicado: (2009)

Getting to the “Heart” of the Matter on Diabetic Cardiovascular Disease: “Thanks for the Memory”
por: Cefalu, William T., et al.
Publicado: (2016)

Is There Evidence That Oral Hypoglycemic Agents Reduce Cardiovascular Morbidity/Mortality? Yes
por: Bianchi, Cristina, et al.
Publicado: (2009)

Cardiovascular Importance of Hyperglycemia and Hypoglycemia
por: Tkáč, Ivan
Publicado: (2013)

The Munich Myocardial Infarction Registry: Translating the European Society of Cardiology (ESC) and European Association for the Study of Diabetes (EASD) guidelines on diabetes, pre-diabetes, and cardiovascular disease into clinical practice
por: Schnell, Oliver, et al.
Publicado: (2009)

Distribution of echocardiographic parameters and their associations with cardiovascular risk factors in the Rotterdam Study
por: Kardys, Isabella, et al.
Publicado: (2010)

Rivaroxaban compared with low-dose aspirin in individuals with type 2 diabetes and high cardiovascular risk: a randomised trial to assess effects on endothelial function, platelet activation and vascular biomarkers
por: Pistrosch, Frank, et al.
Publicado: (2021)

Cardiovascular risk and protective factors in adults with and without diabetes mellitus (Italy, 2016–19)
por: Baldissera, Sandro, et al.
Publicado: (2022)

Cardiovascular benefits and safety profile of acarbose therapy in prediabetes and established type 2 diabetes
por: Hanefeld, Markolf
Publicado: (2007)

Intra-individual variability and circadian rhythm of vascular endothelial growth factors in subjects with normal glucose tolerance and type 2 diabetes
por: Hanefeld, Markolf, et al.
Publicado: (2017)

Insulin Use Early in the Course of Type 2 Diabetes Mellitus: The ORIGIN Trial
por: Hanefeld, Markolf, et al.
Publicado: (2013)

Distribution of hyperglycaemia and related cardiovascular disease risk factors in low-income countries: a cross-sectional population-based survey in rural Uganda
por: Maher, Dermot, et al.
Publicado: (2011)

A Summary of the ADVANCE Trial
por: Heller, Simon R.
Publicado: (2009)

Heart in Diabetes: A Microvascular Disease
por: Laakso, Markku
Publicado: (2011)

Heart in Diabetes: Not Only a Macrovascular Disease
por: Stratmann, Bernd, et al.
Publicado: (2011)

Should C-Reactive Protein Be a Target of Therapy?
por: Oh, Jisun, et al.
Publicado: (2011)

Bone mineral density and risk of cardiovascular disease in men and women: the HUNT study
por: Bhatta, Laxmi, et al.
Publicado: (2021)

Cardiovascular care of patients with stroke and high risk of stroke: The need for interdisciplinary action: A consensus report from the European Society of Cardiology Cardiovascular Round Table
por: Doehner, Wolfram, et al.
Publicado: (2019)

Sodium and potassium intake and risk of cardiovascular events and all-cause mortality: the Rotterdam Study
por: Geleijnse, Johanna M., et al.
Publicado: (2007)

Nonfasting triglycerides and risk of cardiovascular death in men and women from the Norwegian Counties Study
por: Lindman, Anja S., et al.
Publicado: (2010)

Antiplatelet Therapy for Every Diabetic Person?
por: Nicolucci, Antonio, et al.
Publicado: (2011)

Shifting the Disease Management Paradigm From Glucose: What are the pros?
por: Stirban, Alin, et al.
Publicado: (2009)

Implications of Postprandial Glucose and Weight Control in People With Type 2 Diabetes: Understanding and implementing the International Diabetes Federation guidelines
por: Gallwitz, Baptist
Publicado: (2009)

The value of pregnancy complication history for 10-year cardiovascular disease risk prediction in middle-aged women
por: Timpka, Simon, et al.
Publicado: (2018)

Milk intake, lactase persistence genotype, plasma proteins and risks of cardiovascular events in the Swedish general population
por: Zhang, Shunming, et al.
Publicado: (2023)

Cardiovascular mortality trends in Switzerland 1995–2018
por: Sorrentino, Lisa, et al.
Publicado: (2022)

Hyperglycemia in Severe and Critical COVID-19 Patients: Risk Factors and Outcomes
por: Le, Viet Tran, et al.
Publicado: (2022)

A CARDIOVASCULAR COMPLICATION OF COVID-19: DELAYED PRESENTATION OF ACUTE MYOPERICARDITIS
por: Akula, Navya, et al.
Publicado: (2020)

Genetic liability to insomnia in relation to cardiovascular diseases: a Mendelian randomisation study
por: Yuan, Shuai, et al.
Publicado: (2021)

Effects of canagliflozin on cardiovascular risk factors in patients with type 2 diabetes mellitus
por: Budoff, Matthew J., et al.
Publicado: (2017)

Changes in treatment of hyperglycemia in a hypertensive type 2 diabetes population as renal function declines
por: Weinrauch, Larry A., et al.
Publicado: (2017)

Prevalence of hyperglycemia in masters athletes
por: Climstein, Mike, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sunhd7938moi319m3nnkt64p29